Ceapins block the unfolded protein response sensor ATF6α by inducing a neomorphic inter-organelle tether. by Torres, Sandra Elizabeth et al.
UCSF
UC San Francisco Previously Published Works
Title
Ceapins block the unfolded protein response sensor ATF6α by inducing a neomorphic inter-
organelle tether.
Permalink
https://escholarship.org/uc/item/8d84023q
Journal
eLife, 8
ISSN
2050-084X
Authors
Torres, Sandra Elizabeth
Gallagher, Ciara M
Plate, Lars
et al.
Publication Date
2019-05-31
DOI
10.7554/elife.46595
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
  
1 
Ceapins block the unfolded protein response sensor ATF6α by inducing a neomorphic 1 
inter-organelle tether 2 
 3 
Sandra E. Torres
1,2,3
, Ciara M. Gallagher
2,3,5,#
, Lars Plate
4,#
, Meghna Gupta
2
, Christina R. 4 
Liem
1,3
, Xiaoyan Guo
6
, Ruilin Tian
6
, Robert M. Stroud
2
, Martin Kampmann
6
, Jonathan S. 5 
Weissman
1,3,* 
& Peter Walter
2,3,*
 6 
 7 
1
Department of Cellular and Molecular Pharmacology, University of California San Francisco, 8 
San Francisco, CA, USA 9 
2
 Department of Biochemistry and Biophysics, University of California at San Francisco, San 10 
Francisco, CA 11 
3
 Howard Hughes Medical Institute, University of California San Francisco, San Francisco, CA 12 
4
 Departments of Chemistry and Biological Sciences, Vanderbilt University, Nashville, TN, USA 13 
5
 Current address: Cairn Biosciences, San Francisco, California, United States 14 
6
 Institute for Neurodegenerative Diseases, Department of Biochemistry and Biophysics, 15 
University of California, San Francisco and Chan Zuckerberg Biohub, San Francisco, California, 16 
USA 17 
 18 
#
 These authors contributed equally 19 
 20 
* Correspondence to: peter@walterlab.ucsf.edu (P.W.), jonathan.weissman@ucsf.edu (J.S.W.)  21 
  
2 
Abstract 22 
The unfolded protein response (UPR) detects and restores deficits in the endoplasmic 23 
reticulum (ER) protein folding capacity. Ceapins specifically inhibit the UPR sensor ATF6α, an 24 
ER-tethered transcription factor, by retaining it at the ER through an unknown mechanism. Our 25 
genome-wide CRISPR interference (CRISPRi) screen reveals that Ceapins function is 26 
completely dependent on the ABCD3 peroxisomal transporter. Proteomics studies establish that 27 
ABCD3 physically associates with ER-resident ATF6α in cells and in vitro in a Ceapin-28 
dependent manner. Ceapins induce the neomorphic association of ER and peroxisomes by 29 
directly tethering the cytosolic domain of ATF6α to ABCD3’s transmembrane regions without 30 
inhibiting or depending on ABCD3 transporter activity. Thus, our studies reveal that Ceapins 31 
function by chemical-induced misdirection which explains their remarkable specificity and opens 32 
up new mechanistic routes for drug development and synthetic biology. 33 
  34 
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Introduction 35 
 36 
The endoplasmic reticulum (ER) is the site of folding and assembly of secreted and 37 
transmembrane proteins. When ER homeostasis is disturbed, misfolded proteins accumulate and 38 
activate the unfolded protein response (UPR) (Walter and Ron, 2011). One of the ER-resident 39 
UPR sensors, ATF6α, is an ER-tethered transcription factor that is cytoprotective and necessary 40 
for cell survival when cells experience ER stress (Wu et al., 2007; Yamamoto et al., 2007). 41 
Under stress conditions, ATF6α traffics to the Golgi apparatus, where it undergoes 42 
intramembrane proteolysis, releasing a bZIP transcription factor domain that moves to the 43 
nucleus and activates transcription (Haze et al.,1999;Yoshida et al., 1998). The events leading to 44 
ATF6α activation and trafficking remain poorly understood, but require the Golgi-resident 45 
proteases S1P and S2P and general components involved in COPII trafficking (Nadanaka et al., 46 
2004; Okada et al., 2003; Schindler and Schekman, 2009; Ye et al., 2000) that are not specific to 47 
ATF6α.  48 
 49 
Using a cell-based high-throughput screen, we recently identified a series of selective 50 
small-molecule inhibitors of ATF6α signaling, termed Ceapins (from the Irish verb “ceap” 51 
meaning “to trap”) (Gallagher et al., 2016). Ceapins act on the most upstream step of ATF6α 52 
activation by retaining ATF6α at the ER and excluding it from ER exit sites during ER stress. 53 
When this trafficking requirement is removed by collapsing the Golgi apparatus into the ER, 54 
making ATF6α accessible to S1P and S2P, ATF6α is still cleavable by the proteases in the 55 
presence of Ceapin. Upon Ceapin treatment, ATF6α rapidly and reversibly forms foci without 56 
requiring new protein synthesis (Gallagher et al., 2016; Gallagher & Walter, 2016). The 57 
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molecular target(s) of Ceapins, let alone how Ceapins specifically inhibit ATF6α, especially in 58 
light of the fact that activation depends on components that are shared by other cellular process, 59 
have remained an enigma. 60 
 61 
To identify the molecular target of Ceapin, we carried out an unbiased genome-wide 62 
screen and proteomic analysis. Our approaches converged on a single target, the peroxisomal 63 
transporter ABCD3. ATF6α and ABCD3 normally do not interact and, indeed, localize to 64 
different parts of the cell. Ceapins induce these novel physical associations between ATF6α and 65 
ABCD3 in cells and in vitro. Our results indicate that Ceapins achieve their remarkable 66 
specificity through an unprecedented mechanism of small molecule induced inter-organelle 67 
tethering.  68 
 69 
Results 70 
  71 
ABCD3 KD desensitizes cells to Ceapin-A7 72 
 73 
To decipher the molecular mechanism of Ceapins, we carried out a genome-wide 74 
CRISPR interference (CRISPRi) screen to identify genes whose knockdown (KD) resulted in 75 
reduced or enhanced sensitivity to the drug. To this end, we screened a genome-wide sgRNA 76 
library (Horlbeck et al., 2016) in K562 cells that stably expressed dCas9-KRAB and an mCherry 77 
transcriptional reporter dependent on ATF6α activation (Figure 1A). Treatment with tunicamycin 78 
(Tm), which blocks N-linked glycosylation, activates ATF6α signaling leading to a two-fold 79 
reporter induction that was completely dependent on ATF6α (Figure 1A). As a positive control, 80 
knocking down MBTPS2, one of the Golgi proteases that processes ATF6α, also inhibited 81 
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induction of the reporter (Figure 1- figure supplement 1A), whereas knocking down HSPA5, 82 
encoding the major Hsp70-type ER chaperone BiP (Binding Protein), induced ER stress and the 83 
reporter constitutively (Figure 1 - figure supplement 1B).   84 
 85 
To carry out our genome-wide screen, we transduced the K562 ATF6α reporter cell line 86 
and selected for sgRNA expressing cells. We then induced ER stress with Tm in the presence or 87 
absence of Ceapin-A7, a potent member of the Ceapin family, and sorted cells by FACS 88 
(fluorescence-activated cell sorting). We isolated populations with decreased or increased 89 
ATF6α signaling (bottom 30% and top 30% of the reporter signal distributions, respectively) and 90 
used next-generation sequencing to quantify frequencies of cells expressing each sgRNA in both 91 
pools to evaluate how expression of each individual sgRNA affects activation of the ATF6α 92 
reporter (Adamson et al., 2016; Sidrauski et al., 2015) (Figure 1B).  93 
 94 
As expected, KD of ATF6α or MBTPS2 (encoding S2P) inhibited reporter induction 95 
(Figure 1C). Knocking down abundant ER quality control components such as HSPA5, induced 96 
ER stress and turned on the reporter independently of Ceapin treatment (labeled in red in Figure 97 
1C, Figure 1 - figure supplement 1C-D). Ceapin independent genes localized to the diagonal 98 
because their knockdown changed the expression of the reporter to the same degree in both 99 
treatments (labeled in red in Figure 1 - figure supplement 1C). Of particular interest were genes 100 
whose KD specifically made cells insensitive to Ceapin treatment allowing activation of the 101 
reporter by Tm in the presence of Ceapin (labeled in black in Figure 1 - figure supplement 1C). 102 
Two genes, ABCD3 and PEX19, robustly retested among the more than twenty hits from the 103 
genetic screen we individually knocked down and tested in the ERSE reporter cell line.  104 
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ABCD3, which encodes a peroxisomal ABC transporter involved in long-chain fatty acid 105 
import into peroxisomes, desensitized cells to Ceapin treatment (Figure 1C, Figure 1 - figure 106 
supplement 1C-D). Additionally, PEX19, which is necessary for chaperoning and targeting 107 
ABCD3 to the peroxisome, also desensitized cells to Ceapin treatment (Figure 1C, Figure 1 - 108 
figure supplement. 1C-D).  We knocked down these candidates individually and performed 109 
ERSE-mCherry dose response assays using Tm. Retesting of these candidates revealed that 110 
ABCD3 and PEX19 KD cells remained completely insensitive to Ceapin-A7 at saturating 111 
concentrations (Figure 1D, Figure 2 - figure supplement 3A). To determine if ATF6α trafficking, 112 
processing, or activation is altered in ABCD3 KD cells, we then measured ATF6α nuclear 113 
translocation (Figure 1 - figure supplement 2) and the downstream ATF6α-N activation of the 114 
reporter and endogenous ATF6α target genes HSPA5 and HSP90B1 (Figure 1E-G). In the 115 
absence of ER stress,  ABCD3 or PEX19 KD cells also do not cause constitutive nuclear 116 
translocation nor activate ATF6α (Figure 1E-G, Figure 1 - figure supplement 2, Figure 2 - figure 117 
supplement 3B). Furthermore, in the presence of ER stress, ABCD3 or PEX19 KD alone did not 118 
impede ATF6α nuclear translocation nor activation (Figure 1E-G, Figure 2 - figure supplement 119 
3B). These results indicate that neither ABCD3 nor PEX19 have direct roles in ATF6α signaling, 120 
posing the question of how Ceapins functionally connect proteins that reside in separate 121 
organelles.  122 
 123 
ABCD3 is required for Ceapin-induced ATF6α foci 124 
 125 
Ceapin treatment induces rapid and reversible formation of ATF6α foci that are retained 126 
in the ER (Figure 2A) (Gallagher et al., 2016; Gallagher & Walter, 2016). We next tested if 127 
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ABCD3 was directly involved in the formation of these foci and would colocalize with ATF6α. 128 
Indeed, in Ceapin-treated cells, ATF6α colocalized with ABCD3 as visualized by 129 
immunofluorescence (Figure 2A-B). This result was surprising because newly synthesized 130 
ABCD3 is inserted directly into the peroxisomal membrane using PEX19 as import receptor 131 
(Imanaka et al., 1996; Biermanns and Gärtner, 2001; Kashiwayama et al., 2007; Kashiwayama et 132 
al., 2005; Sacksteder et al., 2000). ABCD3 is not co-translationally translocated into the ER, 133 
indicating there is not a pool of ABCD3 in the ER (Figure 2 - figure supplement 1) (Jan et al., 134 
2014); indeed, it is commonly used as a reliable marker for peroxisomes (Uhlén et al., 2015). 135 
Since both ABCD3 and PEX19 scored as hits in our screen, it seemed plausible that Ceapin 136 
induces ATF6α colocalization with peroxisomal ABCD3. We next tested whether ATF6α also 137 
colocalized with other peroxisomal markers, peroxisomal membrane protein PEX14 and 138 
peroxisomal matrix protein Thiolase (a maker for mature import competent peroxisomes).  In the 139 
absence of Ceapin, ATF6α and PEX14 or Thiolase did not colocalize (Figure 2A, C, Figure 2 – 140 
figure supplement 2). By contrast, in the presence of Ceapin, we observed ATF6α and PEX14 141 
and Thiolase colocalization (Figure 2A, C Figure 2 – figure supplement 2). Furthermore, in 142 
ABCD3 KD cells treated with Ceapin, ATF6α no longer formed foci or colocalized with 143 
peroxisomes (Figure 2A, C). This result was consistent in PEX19 KD cells, where peroxisome 144 
biogenesis is affected and ABCD3 is no longer chaperoned and targeted to the peroxisome 145 
(Kashiwayama et al., 2007; Kashiwayama et al., 2005; Sacksteder et al., 2000), ATF6α no longer 146 
formed foci in the presence of Ceapin (Figure 2 - figure supplement 3C). Thus, peroxisomes 147 
interact with Ceapin-induced ATF6α foci in an ABCD3-dependent fashion to sequester ATF6α 148 
at the ER.   149 
 150 
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After prolonged ER stress, ATF6α attenuates and forms foci that are reminiscent of 151 
Ceapin induced foci (Gallagher & Walter, 2016). We next asked whether Ceapin was acting on 152 
the normal mechanism of ATF6α attenuation by testing ABCD3 colocalization with stress 153 
attenuated ATF6α foci. To induce stress attenuated ATF6α foci, we treated U2OS cells 154 
expressing GFP-ATF6α with ER stress, Tm or Tg (thapsigargin, which inhibits the ER calcium 155 
pump) for 2 and 4 hours. In positive control cells treated with Ceapin, ATF6α colocalized with 156 
ABCD3 and PEX14. In stress induced cells, attenuated ATF6α foci did not colocalize with 157 
ABCD3 or PEX14 by immunofluorescence (Figure 2D-E). Thus, Ceapin does not act on the 158 
ATF6α pathway by stabilizing the attenuated ATF6α state. The stress attenuated foci and Ceapin 159 
induced foci are distinct.  160 
 161 
Ceapin treatment does not inhibit ABCD3 activity 162 
 163 
Since Ceapin treatment inhibits ATF6α, we next tested whether Ceapin treatment also 164 
inhibits ABCD3. ABCD3 knockout mice and hepatocytes display defects in bile acid 165 
biosynthesis (Ferdinandusse et al., 2015). To test if Ceapin treatment affects ABCD3 activity, we 166 
measured bile acid levels in a liver cancer cell line (HepG2) after Ceapin treatment and ABCD3 167 
KD. As expected, in ABCD3 KD cells, bile acid levels were decreased (Figure 3). In control 168 
cells treated at the EC50 and ten-times the EC50 of Ceapin, bile acid levels were similar to cells 169 
treated with vehicle only (Figure 3). Thus, Ceapin does not inhibit ABCD3 activity in cells.  170 
 171 
Ceapin-induced ATF6α-ABCD3 interaction does not require known ER-peroxisome 172 
tethers 173 
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 174 
The tight association between the ER and peroxisome is mediated by ER-peroxisome 175 
tethers, VAPA and VAPB on the ER and ACBD4 and ACBD5 on the peroxisomes (Costello et 176 
al., 2017; Costello et al., 2017; Hua et al., 2017). While the ER components are redundant, 177 
ACBD5 KD or overexpression alone decreases or increase ER-peroxisome contacts, respectively 178 
(Costello et al., 2017; Hua et al., 2017). To determine whether proximity between the ER and 179 
peroxisomes induced by these tethers is required for Ceapin-induced foci formation, we 180 
knocked-down these known ER-peroxisome tethers. In tether KD cells treated with Ceapin, 181 
ATF6α foci still formed and ATF6α colocalized with ABCD3 (Figure 4A-B). Additionally, 182 
tether KD cells were not resistant to Ceapin treatment (Figure 4C), consistent with the results 183 
from our screen in which these components also did not score as hits.  184 
 185 
Ceapin-induced interactions do not require ER localized ATF6α nor ABCD3 transporter 186 
activity 187 
 188 
We next tested if ER membrane association of ATF6α is required for Ceapin induced 189 
foci. To this end, we knocked down endogenous ATF6α and FACS sorted for a narrow, low 190 
level of GFP expression for truncated variants of ATF6α containing its cytosolic regions without 191 
the transmembrane and ER-lumenal domains (Figure 5A). We found that GFP-ATF6α(2-302), 192 
which was retained in the cytosol with a nuclear exit signal and was no longer associated with 193 
the ER,  colocalized with ABCD3 and formed foci (Figure 5A-B). Further truncations showed 194 
that only the first 89 amino acids of ATF6α were both necessary and sufficient for Ceapin-195 
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dependent foci formation and colocalization with ABCD3 and peroxisomes (Figure 5A-B, Figure 196 
5 - figure supplement 1).  197 
 198 
Since ABCD3 is a transporter, we then tested if ABCD3 catalytic activity was required 199 
for Ceapin action. Similarly to our ATF6α truncations, we also knocked down endogenous 200 
ABCD3 and FACS sorted for low level GFP expression of constructs with mutations of ABCD3 201 
residues that mediate ATP binding (G478R) and hydrolysis (S572I) or a deletion of the entire 202 
catalytic domain (Roerig et al.,  2001). There is one reported patient with a C terminal truncation 203 
of ABCD3 in which a reduced number of import competent peroxisomes are present 204 
(Ferdinandusse et al., 2015).  Similarly, GFP-ABCDNBD cells, with a deletion of the entire 205 
catalytic domain, have reduced, enlarged peroxisomes (Figure 5C, Figure 5 - figure supplement 206 
2). We also confirmed correct localization of the GFP-ABCD3 constructs to the peroxisome 207 
(Figure 5 - figure supplement 2). As a positive control, ABCD3 KD cells complemented with the 208 
full length ABCD3 construct were able to colocalize with and form ATF6α foci when treated 209 
with Ceapin (Figure 5C-D).  In our catalytic activity mutants, we found that ABCD3 ATP 210 
binding or hydrolysis was not required for Ceapin-induced foci formation (Figure 5C-D).  211 
Although there are fewer larger peroxisomes in GFP-ABCDNBD cells, peroxisomal ABCD3 212 
still induced foci formation and colocalized with ATF6α in the presence of Ceapin (Figure 5C-213 
D). These results indicate that Ceapin-induced interactions do not require ER localized ATF6α 214 
nor ABCD3 transporter activity.  215 
 216 
Ceapin drives ATF6α-ABCD3 interaction in cells and in vitro. 217 
 218 
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To identify components physically associating with ATF6α in the presence of Ceapin, we 219 
carried out native immunoprecipitation – mass spectrometric (IP-MS) analyses. We treated 220 
3xFLAG-ATF6α HEK293 cells with Ceapin-A7 or an inactive analog, Ceapin-A5, in the 221 
presence of stress (Tg) and found that ABCD3 co-purified as the top hit with epitope-tagged 222 
ATF6α selectively in the presence of active Ceapin-A7 but not inactive Ceapin-A5 (Figure 6A-223 
B). The native reciprocal affinity purification with full-length GFP-ABCD3 cells confirmed 224 
these results (Figure 6C). Furthermore, GFP-ABCDNBD, lacking the entire nucleotide 225 
binding domain, also physically associated with ATF6α in the presence of Ceapin (Figure 6C). 226 
 227 
We then tested if the minimal cytosolic domain of ATF6α, GFP-ATF6α(2-90), physically 228 
associated with peroxisomal ABCD3. We immunoprecipitated GFP-ATF6α(2-90) from 229 
detergent solubilized lysates and specifically enriched ABCD3 in the presence of active Ceapin-230 
A7 but not inactive Ceapin-A5 (Figure 6D). Thus, consistent with the above experiments where 231 
organelle tethering was not required, these results confirm that no other ER proteins are required 232 
for Ceapin-A7 induced ATF6α and ABCD3 physical association.  233 
 234 
Finally, we tested whether purified ATF6α and ABCD3 were sufficient for Ceapin-235 
induced tethering. In a binding assay with purified ATF6α(2-90) and ABCD3, our vehicle 236 
(DMSO) and inactive Ceapin-A5 controls did not induce ATF6α(2-90) and ABCD3 binding 237 
(Figure 6E). In the presence of Ceapin-A7, however, the cytosolic domain of ATF6α(2-90) and 238 
ABCD3 associated in solution (Figure 6E). Thus, Ceapin is directly responsible for tethering 239 
ABCD3 to ATF6α. 240 
 241 
  
12 
Discussion 242 
 243 
 Ceapins, named for their ability to trap ATF6α in the ER, act with exquisite selectivity; 244 
they do not affect signaling of ATF6α’s close homolog ATF6 or SREBP (sterol response 245 
element binding protein) (Gallagher et al., 2016), which depend on broadly used vesicular 246 
trafficking ER-Golgi pathways and are activated by the same Golgi-resident proteases 247 
(Nadanaka et al., 2004; Okada et al., 2003; Schindler and Schekman, 2009; Ye et al., 2000).  248 
Here we discovered the basis of this specificity. Ceapins induce neomorphic inter-organelle 249 
junctions, forcing interactions between the cytosolic domain of ER-tethered ATF6α and the 250 
peroxisomal transmembrane protein ABCD3 to sequester ATF6α from its normal trafficking 251 
route (Figure 7), and do so without interfering with or depending on ABCD3’s normal function. 252 
Since ABCD3 protein expression is ten-fold higher than ATF6 (Hein et al., 2015), it is likely 253 
ABCD3 is not saturated. Ceapin induced interaction of ABCD3 with the most N-terminal region 254 
of ATF6α also clarifies how ATF6α foci are excluded from COPII trafficking, while the 255 
transmembrane region of ATF6α remains accessible to protease cleavage. Mechanistically, 256 
Ceapins could act as molecular staples that physically bridge the respective proteins or bind to 257 
one or the other inducing allosteric changes that promote their association; but in either case, 258 
Ceapin is responsible for tethering ABCD3 to ATF6α.  259 
 260 
Remarkably, in the absence of Ceapins, ATF6α and ABCD3 localize to different parts of 261 
the cell and are not known to interact physically or functionally. Indeed, an 89-amino acid 262 
fragment of ATF6α fused to GFP is sufficient to recruit GFP to peroxisomes, ruling out the need 263 
for endogenous inter-organellar tethers. This Ceapin-induced tethering enables an “anchor away” 264 
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strategy but one that uses an abundant, ubiquitously expressed endogenous acceptor protein. 265 
There has been increasing interest in small molecules that induce novel protein-protein 266 
interactions with therapeutic potential (De Waal et al., 2016; Han et al., 2017; Krönke et al., 267 
2014; Lu et al., 2014; Petzold et al., 2016; Uehara et al., 2017). Ceapins provide a novel example 268 
of such molecules and increase the repertoire to include the induction of inter-organellar 269 
connections, opening new mechanistic routes for drug development and synthetic biology by 270 
broadly enabling control of protein function through chemical-induced misdirection.  271 
 272 
Understanding the mechanism of action of a chemical modulator of cellular stress and 273 
establishing that it is acting directly and specifically is critical for exploiting the utility of any 274 
stress modulators either as research or potential therapeutic agents. Our identification of the 275 
mechanism by which Ceapins achieve their remarkable specificity forms a foundation to explore 276 
the utility of ATF6α inhibition in the treatment of cancers, such as squamous carcinomas, in 277 
which ATF6α signaling protects dormant tumor cells from classical chemotherapies (Schewe and 278 
Aguirre-Ghiso, 2008).  279 
  280 
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Figures 295 
 296 
Figure 1. ABCD3 KD desensitizes cells to Ceapin-A7.  297 
(A) Schematic of the ER stress element (ERSE) reporter cassette. K562 ERSE reporter cells 298 
were transduced with the indicated sgRNAs and treated with vehicle (DMSO) or tunicamycin 299 
(Tm) (6 g/ml) for 16 h. (B) Schematic of the CRISPRi screen to identify the target of Ceapin. 300 
K562 cells expressing the ERSE reporter were transduced with the sgRNA library. The 301 
population was then divided into two subpopulations, which were treated with Tm or Tm plus 302 
Ceapin-A7 at EC90 (3 M) for 16 h. Cells in the top and bottom thirds of mCherry fluorescence 303 
of each subpopulation (Tm-treatment and Tm + Ceapin-treatment) were collected by FACS and 304 
processed to measure the frequencies of sgRNAs contained within each. (C) Volcano plot of 305 
gene-reporter phenotypes and p values from CRISPRi screen. Negative control sgRNA targeted 306 
genes (grey), Ceapin-independent genes (red), genes with growth phenotypes (blue), and Ceapin 307 
hits (black) are indicated.  denotes chromatin architecture and remodeling related genes that 308 
impact reporter transcription. The reporter phenotypes and p values for genes in CRISPRi screen 309 
are listed in Figure 1- source data 1.  (D) K562 ERSE reporter cells with individual ABCD3 310 
sgRNAs or control sgRNA (NegCtrl) were treated with Tm and increasing concentrations of 311 
Ceapin-A7 for 16 h.  Reporter fluorescence was measured by flow cytometry and median values 312 
were plotted (N = 3, ± SD). (E) K562 ERSE reporter ABCD3 and NegCtrl KD cells were treated 313 
with DMSO or Tm and reporter activation was measured as in (D). (F and G) qPCR analysis of 314 
ATF6α target genes HSPA5 and HSP90B1, respectively. HepG2 CRISPRi NegCrl and ABCD3 315 
KD cell lines were treated with DMSO, thapsigargin  (Tg) (100 nM), and Tg with Ceapin (6 316 
M). Tg blocks the ER calcium pump and induces ER stress. Data plotted are mRNA levels for 317 
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HSPA5 and HSP90B1 normalized to GAPDH and then compared to unstressed NegCtrl cells ± 318 
standard deviation of duplicate technical replicates of two biological replicates. 319 
 320 
Figure 1 – source data 1. Reporter phenotypes and p values for genes in CRISPRi screen. 321 
 322 
Figure 1 - figure supplement 1. Genome-scale CRISPRi screen to identify molecular target 323 
of Ceapin 324 
(A and B)  K562 ERSE reporter cells were transduced with the indicated sgRNAs and treated 325 
with vehicle (DMSO) or tunicamycin (Tm) (6 g/ml) for 16 h. (C) Reporter phenotypes from 326 
CRISPRi screens treated with ER stress in the absence (x-axis) and presence (y-axis) of 327 
Ceapin. Ceapin-independent genes (labeled in red) are genes whose knockdown changed the 328 
expression of the reporter to the same degree in both treatments and localized to the diagonal. 329 
Genes with growth phenotypes of at least -0.19 in previous growth screens (12) are labeled in 330 
blue.  denotes chromatin architecture and remodeling related genes that impact reporter 331 
transcription. Negative control genes are labeled in grey. (D) Volcano plot of gene-reporter 332 
phenotypes and p values from CRISPRi screen described in (Figure 1C) and shown on y-axis of 333 
(A) with additional genes labeled. The reporter phenotypes and p values for genes in CRISPRi 334 
screen are listed in Figure 1- source data 1.   335 
 336 
Figure 1 - figure supplement 2. ABCD3 KD does not affect ATF6α nuclear translocation.  337 
Quantification of nuclear translocation of ATF6α. Endogenous ABCD3 was knocked-down in 338 
3xFLAG-ATF6α HEK293 CRISPRi cells and full length GFP-ABCD3 construct was added back 339 
by FACS soring for narrow, low GFP levels. Data plotted is the ratio of ATF6α signal intensity 340 
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of nucleus to ER per cell, from one of three independent experiments and with at least twenty 341 
cells per condition. Statistical analysis used unpaired two-tailed t-tests, **** indicates p < 342 
0.0001.   343 
 344 
Figure 2. ABCD3 is required for Ceapin-induced ATF6α foci.  345 
(A) HEK293 CRISPRi cells stably expressing doxycycline inducible 3xFLAG-ATF6α with 346 
ABCD3 or NegCtrl KD were treated either with DMSO or Ceapin (6 M) for 30 min prior to 347 
fixation, staining with anti-ABCD3 and/or anti-PEX14, and confocal fluorescent imaging. Scale 348 
bar, 10 m. Images are representative of two independent experiments, in which we imaged at 349 
least 20 positions per well for each experiment. (B and C) Plotted is the mean and standard 350 
deviation of the mean per cell correlation of 3xFLAG-ATF6α and ABCD3 or PEX14 from (A) 351 
with at least 30 cells imaged per condition. All cells imaged in ABCD3 KD (96% KD), including 352 
wildtype cells, were used in quantification.  Statistical analysis used unpaired two-tailed t-tests, 353 
**** indicates p < 0.0001.  (D) U2-OS cells stably expressing GFP-ATF6α were treated either 354 
with vehicle (DMSO), Tg (100 nM), Tm (2 g/ml), or Ceapin (6 M) for 2 h or 4 h (shown) 355 
prior to fixation, co-staining with anti-ABCD3 and anti-PEX14, and fluorescent imaging. Stress 356 
attenuated GFP-ATF6α foci are indicated by arrowheads. Scale bar, 10 m. (E) Quantification of 357 
correlation of GFP-ATF6α and ABCD3 within PEX14 sites.  358 
 359 
Figure 2 - figure supplement 1. ABCD3 is not co-translationally translocated into the ER.  360 
Data from Jan et al. 2014 is plotted. Gene enrichments obtained with the general BirA-Sec61ß 361 
ER marker in HEK293 cells and SS annotations predicted by SignalP. ABCD4 was previously 362 
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annotated to be peroxisomal, but recently shown to be ER localized. PEX16 has been previously 363 
shown to be co-translationally translocated. PXPM2 is a peroxisomal membrane protein.  364 
 365 
Figure 2 - figure supplement 2. Ceapin-induced ATF6α foci colocalize with peroxisomal 366 
matrix protein Thiolase.  367 
(A) 3xFLAG-ATF6α HEK293 CRISPRi cells with NegCtrl KD were treated and fixed as in 368 
Figure 2A and stained for Thiolase. Scale bar, 10 m. (B) Quantification of the correlation of 369 
ATF6α and Thiolase from (A) and plotted as in Figure 2B. 370 
 371 
Figure 2 - figure supplement 3. PEX19 KD desensitizes cells to Ceapin and is required for 372 
Ceapin-induced ATF6α foci 373 
(A) K562 ERSE reporter cells with NegCtrl or PEX19 sgRNA KD were treated with ER stressor 374 
(6 g/ml Tm) and increasing concentrations of Ceapin-A7 for 16 h.  Reporter fluorescence was 375 
measured by flow cytometry and median values were plotted (N = 3, ± SD). (B) K562 ERSE 376 
reporter PEX19 and NegCtrl KD cells were treated without (DMSO) or with ER stressor (Tm) 377 
and reporter activation was measured as in (A). (C) 3xFLAG-ATF6α HEK293 CRISPRi cells 378 
with PEX19 sgRNA or NegCtrl KD were treated, fixed, and stained as in Figure 2A. Scale bar, 379 
10 m.  380 
 381 
Figure 3. Ceapin treatment does not inhibit ABCD3 activity  382 
Bile acid levels were measured in HepG2 CRISPRi cells with NegCtrl or ABCD3 KD treated 383 
with vehicle (DMSO), EC50 of Ceapin (600nM), and ten times the EC50 of Ceapin-A7 (6 M).  384 
 385 
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Figure 4. Ceapin-induced ATF6α-ABCD3 interaction does not require known ER-386 
peroxisome tethers  387 
(A) ER tether components, VAPA and VAPB, and peroxisome tether components, ACBD4 and 388 
ACBD5, were individually knocked-down in 3xFLAG-ATF6α HEK293 CRISPRi cell line, 389 
treated, fixed, and stained as in Figure 2A prior to fluorescence imaging. Scale bar, 10 m. (B) 390 
Quantification of the correlation of ATF6α and ABCD3 from (A) and plotted as in Figure 2B. 391 
(C) K562 ERSE reporter cells with NegCtrl or indicated knockdowns were treated with Tm and 392 
increasing concentrations of Ceapin-A7 for 16 h.  Reporter fluorescence was measured by flow 393 
cytometry and median values were plotted (N = 3, ± SD). 394 
 395 
Figure 5. Ceapin-induced interactions do not require ER localized ATF6α nor ABCD3 396 
transporter activity 397 
(A) Diagram of GFP-ATF6α constructs tested. A nuclear exit signal (NES) was added to ATF6α 398 
truncated constructs to retain ATF6α in the cytosol. Endogenous ATF6α was knocked-down in 399 
3xFLAG-ATF6α HEK293 CRISPRi cells grown without doxycycline, so that only GFP-ATF6α 400 
constructs were expressed. GFP-ATF6α-truncated cell lines were treated with DMSO or Ceapin-401 
A7, fixed and stained for ABCD3. Scale bar, 10 m. (B) Quantification of the correlation of 402 
GFP-ATF6α within ABCD3 sites. (C) Diagram of the GFP-ABCD3 mutants and truncations 403 
tested. Endogenous ABCD3 was knocked-down in 3xFLAG-ATF6α HEK293 CRISPRi cells so 404 
only GFP-ABCD3 constructs were expressed. GFP-ABCD3 cell lines were treated with DMSO 405 
or Ceapin-A7, fixed and stained for  FLAG(ATF6α) (shown) and PEX14. Scale bar, 10 m. (D) 406 
Quantification of the correlation of GFP-ABCD3 and 3xFLAG-ATF6α within PEX14 sites.  407 
 408 
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Figure 5 - figure supplement 1. ATF6α(2-90) colocalizes with peroxisomal matrix protein 409 
Thiolase  410 
(A) Endogenous ATF6 was knocked-down in U2OS Flp-In™ CRISPRi cells and FACS sorted 411 
for narrow, low GFP levels so only GFP-ATF6α(2-90) construct was expressed. Cells were 412 
treated and fixed as in Figure 2A and stained for Thiolase. Scale bar, 10 m. (B) Quantification 413 
of the correlation of ATF6α and Thiolase from (A) and plotted as in Figure 2B. 414 
 415 
Figure 5 - figure supplement 2. ABCD3 constructs localization to peroxisome. 416 
Endogenous ABCD3 was knocked-down in 3xFLAG-ATF6α HEK293 CRISPRi cells and FACS 417 
sorted for narrow, low GFP levels so only GFP-ABCD3 constructs were expressed. GFP-418 
ABCD3 cell lines were treated with DMSO or Ceapin-A7, fixed and stained for PEX14 (shown) 419 
and FLAG(ATF6α). Scale bar, 10 m. 420 
 421 
Figure 6. Ceapin drives ATF6α-ABCD3 interaction in cells and in vitro. 422 
(A and B) Proteomic analysis and immunoblot (IB) of anti-FLAG affinity purification from 423 
3xFLAG-ATF6α HEK293 cells treated with stress (100nM Tg) and inactive Ceapin-A5 analog 424 
(6 or active Ceapin-A7 (6 with two replicates for each treatment condition. The 425 
proteins identified with affinity-purified FLAG-ATF6 treated with ER stress and Ceapin-A5 or 426 
Ceapin-A7 are listed in Figure 6 – source data 1. SQSTM1 KD ( ) was the top second hit in 427 
proteomics, however, SQSTM1 KD in the K562 ATF6 reporter cell line did not render cells 428 
resistant to Ceapin treatment and retained a similar response to negative control cells. I, input; 429 
FT, flow-through; E, elution.  (C) Immunoprecipitation of full-length GFP-ABCD3 and GFP-430 
ABCDNBD from cells treated with DMSO or Ceapin-A7. (D) Detergent solubilized GFP-431 
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ATF6α(2-90) or GFP-only cell lysates were incubated with Ceapin-A7 or inactive analog 432 
Ceapin-A5 and affinity purified with anti-GFP. (*) Indicates a degradation product. (E) Purified 433 
ATF6α-MBP and ABCD3-GFP were incubated with inactive Ceapin-A5 or active Ceapin-A7 434 
and affinity purified with anti-MBP antibody.  435 
 436 
Figure 6 – source data 1. Excel spreadsheet showing all the proteins identified with affinity-437 
purified FLAG-ATF6 treated with ER stress and Ceapin-A5 or Ceapin-A7. 438 
 439 
Figure 7. Model for Ceapin induced ATF6α inhibition. 440 
Ceapins sequester ATF6α into a transport-incompetent pool during ER stress by tethering 441 
ATF6α to peroxisomal ABCD3. ATF6α is occluded from COPII trafficking, while its 442 
transmembrane domain remains accessibly to protease cleavage. 443 
Material and Methods  444 
 445 
Cell culture and experimental reagents 446 
U2OS, 293TREx, and HepG2 cells were cultured in DMEM. K562 cells were cultured in RPMI. 447 
Culture media was supplemented with 10% fetal bovine serum (FBS), 1% L-glutamine, and 1% 448 
penicillin/streptomycin (ThermoFisher). U2-OS cells stably expressing GFP-HsATF6α were 449 
purchased from Thermo Scientific (084_01) and - figure supplemented with 500 g/ml G418 to 450 
maintain GFP-HsATF6α expression. HeLa CRISPRi cells expressing SFFV-dCas9-BFP-KRAB 451 
were previously described (Jost et al., 2017). Tunicamycin and thapsigargin were purchased 452 
from Sigma. Antibodies used were rabbit anti-GFP (ThermoFisher A11122), mouse anti-FLAG 453 
M2 (Sigma F1804), rat anti-GRP94 9G10 (abcam ab2791), rabbit anti-pmp70 (ab109448) for 454 
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PFA fixation and (PA1-650) for methanol fixation, mouse anti-pmp70 (ab211533) for PFA 455 
fixation and (SAB4200181) for methanol fixation.  456 
 457 
Generation of constructs and cell lines  458 
To generate CRISPRi knockdown cell lines, SFFV-dCas9-BFP-KRAB (Addgene 46911) or 459 
UCOE-EF1α-dCas9-BFP-KRAB (Jost et al., 2017) were stably transduced and FACS-sorted for 460 
BFP positive cells. 293 TREx cells expressing doxycycline-inducible 6xHis-3xFLAG-HsATF6α 461 
(Gallagher et al., 2016) were infected with SFFV-dCas9-BFP-KRAB and sorted twice for BFP 462 
expressing cells. HepG2 cells from ATTC (CRL-10741) were infected with UCOE-EF1α-dCas9-463 
BFP-KRAB and FACS sorted for BFP expression. The ERSE reporter construct was generated 464 
by subcloning mCherry into the ERSE.Fluc.pcDNA3.1 (Mortenson et al. 2017) using the 465 
polymerase incomplete primer extension method to replace the FLuc gene. This construct was 466 
then subcloned into ClaI and EcoRI digested pLenti6.V5.GFP. K562 cells stably expressing 467 
dCas9-KRAB (Gilbert et al., 2014) were stably transduced with the ERSE reporter construct and 468 
a monoclonal line was selected and expanded to generate K562 ERSE reporter cell line.  469 
 470 
Individual gene knockdowns were carried out by selecting sgRNA protospacers from compact 471 
hCRISPRi-v2 library and cloning into lentiviral plasmid pU6-sgRNA EF1α-puro-t2a-472 
BFP (Addgene 60955) as previously described (Horlbeck et al., 2016). Protospacer sequences 473 
used for individual knockdowns are listed in Table 1. The resulting sgRNA expression vectors 474 
were packaged into lentivirus by transfecting HEK293T with standard packaging vectors using 475 
TransIT®-LTI Transfection Reagent (Mirus, MIR 2306). The viral supernatant was harvested 2-476 
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3 days after transfection and frozen prior to transduction into CRISPRi knockdown cell lines 477 
described above. 478 
 479 
3xFLAG-ATF6α HEK293 CRISPRi described above was stably transduced with sgRNA 480 
knockdown of endogenous ATF6α or ABCD3 and grown without doxycycline to ascertain that 481 
only truncation constructs would be expressed. ATF6α truncation constructs were generated by 482 
Gibson assembly of IDT gblock of sfGFP and ATF6α PCR amplified from peGFP-HsATF6α 483 
(Addgene #32955) into inserted into BamHI/NotI digested pHR-SFFV-Tet3G (Gilbert et al., 484 
2014). ATF6α truncations were PCR amplified with reverse primers containing nuclear exit 485 
signal (NES) (NES, CTGCCCCCCCTGGAGCGCCTGACCCTG; NES_REV, 486 
CCCCTGCAGCTGCCCCCCCTGGAGCGGCTGACCCTG) to retain ATF6α in the cytosol. 487 
Full length GFP-ABCD3 and GFP-ABCDNBD (2-416) were cloned by Gibson assembly of 488 
ABCD3 PCR amplified from cDNA and IDT gblock of sfGFP into BamHI/NotI digested pHR-489 
SFFV-Tet3G (Gilbert et al., 2014). ABCD3 G478R and S572I mutations were generated by site 490 
directed mutagenesis (QuikChange Lightning Agilent) of full-length GFP-ABCD3 construct. 491 
ATF6α and ABCD3 truncation vectors were packaged into lentivirus as described above, stably 492 
transduced, and FACS sorted for a narrow and low level of GFP expression. 493 
 494 
U2OS Flp-In™ cells were infected with UCOE-EF1α-dCas9-BFP-KRAB and FACS sorted for 495 
BFP expression. They were then stably transduced with sgRNA knockdown of endogenous 496 
ATF6α and GFP-ATF6α(2-90) construct, and FACS sorted for a narrow level of GFP 497 
expression. Parental cell lines and commercially available cell lines were authenticated by STR 498 
analysis and tested negative for mycoplasma contamination. 499 
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 500 
Genome-scale CRISPRi screen  501 
Reporter screens were carried out using protocols similar to those previously described 502 
(Adamson et al., 2016; Gilbert et al., 2014; Sidrauski et al., 2015). The compact (5 sgRNA/gene) 503 
hCRISPRi-v2 (12) sgRNA libraries were transduced into ERSE reporter cells at a MOI <1 (55% 504 
BFP+ cells). Cells were grown in spinner flasks for 2 days without selection, selected with 2 505 
g/ml puromycin for 2 days, and allowed to recover for 3 days. Cells were then split into two 506 
populations, which were treated for 16 h with 6 g/ml tunicamycin alone or 6 g/ml tunicamycin 507 
and 3 M Ceapin (EC90). Cells were then sorted based on reporter fluorescence using BD FACS 508 
Aria2. Cells with the highest (~30%) and lowest (~30%) mCherry expression were collected and 509 
frozen after collection. Approximately 20 million cells were collected per bin. Genomic DNA 510 
was isolated from frozen cells, and the sgRNA-encoded regions were enriched, amplified, and 511 
prepared for sequencing.  512 
 513 
Sequenced protospacer sequences were aligned and data were processed as described (Gilbert et 514 
al., 2014; Horlbeck et al., 2016) with custom Python scripts (available at 515 
https://github.com/mhorlbeck/ScreenProcessing). Reporter phenotypes for library sgRNAs were 516 
calculated as the log2 enrichment of sgRNA sequences identified within the high-expressing 517 
mCherry over the low-expressing mCherry cells. Phenotypes for each transcription start site 518 
were then calculated as the average reporter phenotype of all 5 sgRNAs. Mann-Whitney test p-519 
values were calculated by comparing all sgRNAs targeting a given TSS to the full set of negative 520 
control sgRNAs. For data presented in Figure 1B, screen hits are defined as those genes where 521 
the absolute value of a calculated reporter phenotype over the standard deviation of all evaluated 522 
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phenotypes multiplied by the log10 of the Mann-Whitney p-value for given candidate is greater 523 
than 7. Growth screen data (Horlbeck et al., 2016) was used to label genes with growth 524 
phenotype of at least -0.19. Ceapin independent genes are defined as genes that were hits in 525 
tunicamycin alone and tunicamycin with Ceapin treatment since their phenotype was 526 
independent of Ceapin treatment. Genes involved in chromatin remodeling and architecture have 527 
been previously described in UPR screens to act downstream and directly affect expression of 528 
the reporter (Jonikas et al., 2012). Chromatin related genes that impact reporter expression are 529 
labeled with ( ) in Figure 1  - figure supplement 1C-D.  530 
 531 
Bile Acid Assay 532 
HepG2 CRISPRi ABCD3 KD and NegCtrl cells were treated with DMSO or Ceapin at 600 nM 533 
or 6 M for 24 h. Cells were harvested in scrapping buffer (cold PBS with 10 M MG132 and 534 
1X protease inhibitor), spun down, resuspended in lysis buffer (50 mM Tris pH 7.4, 150 mM 535 
NaCl, 5 mM EDTA, 1X protease inhibitor, and 1% LMNG), and spun down at 10,000 x g for 10 536 
min. The supernatant was used for bile acid assay (Cell Biolabs STA-631) as described by the 537 
manufacturer.  538 
 539 
Quantitative RT-PCR 540 
Cells were harvested and total RNA was isolated using the NucleoSpin RNA II (Macherey-541 
Nagel) according to manufacturer’s instructions. RNA was converted to cDNA using AMV 542 
reverse transcriptase under standard conditions with oligo dT and RNasin (Promega, Life 543 
Technologies). Quantitative PCR reactions were prepared with a 2x master mix according to the 544 
manufacturer’s instructions (KAPA SYBR FAST qPCR Kit). Reactions were performed on a 545 
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LightCycler thermal cycler (Roche). Primers used were against HSPA5 (forward, 546 
TGTGCAGCAGGACATCAAGT: reverse, AGTTCCAGCGTCTTTGGTTG ) and HSP90B1 547 
(forward, GGCCAGTTTGGTGTCGGTTT ; reverse, CGTTCCCCGTCCTAGAGTGTT ).  548 
 549 
Immunofluorescence  550 
Fluorescence confocal imaging was carried out as described in (10,11).  293 TREx, U2OS, 551 
HepG2, and HeLa cells were plated in 8-well ibiTreat μSlide (ibidi 80826) at 20-25,000 552 
cells/well. In 3xFLAG-ATF6α imaging experiments (Figure 2A-C, Figure 2 – figure supplement 553 
2-3, Figure 4A-C, Figure 5A-D, Figure 5 – figure supplement 2), 3xFLAG-ATF6α HEK293 554 
CRISPRi cells were plated and induced with 50nM doxycycline on the same day. On the 555 
following day, cells were treated with DMSO or 6 M Ceapin for 30 min and then fixed with 556 
cold methanol or 4% PFA. For cold methanol fixation, media was removed, cold ethanol was 557 
added for 3 min at -20 C, washed, and permeabilized with PHEM (60 mM PIPES, 25 mM 558 
HEPES, 10 mM EGTA, 2 mM MgCl2, pH 6.9) with 0.1% Triton X-100, and washed twice with 559 
PHEM. For PFA fixation, media was removed from slides, 4% PFA (EMS) was added for 10 560 
min at room temperature, washed, permeabilized as above, and washed with PHEM. Slides were 561 
then treated with blocking buffer (5% goat serum (Jackson ImmunoResearch) in PHEM) for 1 h 562 
at room temperature. Antibodies were diluted in blocking buffer and incubated with cells at 4° C 563 
overnight. After three washes with PHEM, cells were incubated with secondary antibodies 564 
conjugated to Alexa 488, Alexa 568, and/or Alexa 633 (Invitrogen) for 1 h at room temperature. 565 
Slides were imaged on a spinning disk confocal with Yokogawa CSUX A1 scan head, Andor 566 
iXon EMCCD camera and 100x ApoTIRF objective NA 1.49 (Nikon). Linear adjustments were 567 
made using ImageJ. Quantification of correlation between ATF6α with ABCD3 and/or PEX14 568 
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was calculated using CellProfiler 2.1.1. ABCD3 or PEX14 images were used to identify objects, 569 
a background threshold for ATF6α images was set to 1.2, and clumped objects were separated 570 
based on intensity. The resulting ABCD3 or PEX14 outlines were used as masks to count the 571 
ATF6α intensity within ABCD3 or PEX14. Data from CellProfiler was imported into GraphPad 572 
Prism version 6.0 for statistical analysis and plotting. 573 
 574 
Nuclear Translocation Assay  575 
3xFLAG-ATF6α HEK293 CRISPRi cells with ABCD3 KD and ABCD3 KD complemented 576 
with full length GFP-ABCD3 construct were plated in ibidi 96-well ibiTreat μ-plate (ibidi 577 
89626) and induced with 50nM doxycycline on the same day. On the following day, cells were 578 
treated with DMSO or 100 nM Tg for 2 hours and then fixed with 4% PFA as described above. 579 
The plates were then treated with blocking buffer (5% goat serum (Jackson ImmunoResearch) in 580 
PHEM) for 1 h at room temperature. Primary antibodies, mouse anti-FLAG M2 (Sigma F1804) 581 
and rat anti-GRP94 9G10 (abcam ab2791), were diluted in blocking buffer and incubated with 582 
cells at 4° C overnight. After three washes with PHEM, cells were incubated with secondary 583 
antibodies conjugated to Alexa 568 and Alexa 633 (Invitrogen) and nuclear stain (DAPI, 584 
Molecular Probes D-1306, 5 μg/mL) for 1 h at room temperature. Quantification ATF6α signal 585 
in ER and nucleus was calculated using CellProfiler 2.1.1 as described in (Gallagher et al. 2016). 586 
DAPI images were used to identify primary objects and clumped objects were distinguished 587 
based on fluorescence intensity.  The GRP94 images were then used to generate secondary 588 
objects from primary objects using global Otsu two-class thresholding with weighted variance. 589 
The final ER mask was generated  by subtracting the nuclear area from the ER area. Lastly, the 590 
FLAG-ATF6α images were used to calculate FLAG-ATF6α intensity in the nucleus and ER and 591 
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determine the nucleus to ER ratio of each cell.  Data from CellProfiler was exported as a 592 
MATLAB file for analysis and plotted on GraphPad Prism version 6.0.  593 
 594 
Immunoprecipitation and Immunoblot Analysis  595 
Cells were grown in 100 mm plates with two replicates for each treatment condition, treated with 596 
50 nM doxycycline the following day, treated with 100nM Tg and 6uM Ceapin-A5 or 6uM 597 
Ceapin-A7 for 30 min on the day of harvest, and harvested in scrapping buffer (cold PBS with 10 598 
μM MG132 and 1X protease inhibitor).  Ceapin A-7, inactive analog Ceapin A-5, or DMSO 599 
were kept in scrapping and lysis buffers throughout IP.  Cells were lysed for 1 h at 4 C in lysis 600 
buffer (50 mM Tris pH 7.4, 150 mM NaCl, 5 mM EDTA, 1X protease inhibitor, and 1% LMNG 601 
(Anatrace NG322)). The lysates were cleared by centrifugation at 17,000 x g for 30 min.  602 
Dynabeads Protein-G (ThermoFisher) were bound with Sigma FLAG M2 antibody for 1 h at 4 603 
C and crosslinked with 100 M BS3 crosslinker for 30 min.  293 TREx 3XFLAG cell lysates 604 
were then incubated with these FLAG beads for 2 h at 4 C. IP beads were washed with wash 605 
buffer (lysis buffer without LMNG) and boiled and eluted in buffer containing 50 mM Tris pH 606 
6.8, 300 mM NaCl, 2% SDS, and 10 mM EDTA. Protein samples were then precipitated, trypsin 607 
digested, labeled with tandem mass tags (TMT), and analyzed by liquid chromatography-mass 608 
spectrometry using Multidimensional Protein Identification Technology (MuDPIT) , as described 609 
previously (Mortenson et al. 2017; Plate et al. 2018). TMT intensities for proteins detected in 610 
each channel were normalized to the respective TMT intensity of ATF6. TMT ratios for 611 
individual proteins were then calculated between Tg+Ceapin-A7/DMSO treatment or 612 
Tg+Ceapin-A5/DMSO treatment.  613 
 614 
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The reciprocal affinity purification with full-length GFP-ABCD3 or GFP-ABCDNBD cells 615 
was carried out by culturing, treating, and lysing cells as described above. 293 TREx 3XFLAG 616 
GFP-ABCD3 clarified cell lysate was then incubated with GFP-Trap_MA ChromoTek beads for 617 
2 h at 4 C. IP beads were washed with wash buffer (lysis buffer without LMNG) and boiled in 618 
SDS sample buffer for 10 min.  619 
 620 
Cells for in vitro incubation were lysed with lysis buffer containing LMNG (described above) 621 
and cleared by centrifugation at 17,000 x g for 30 min in the absence of any drug. Cleared 622 
supernatant was then incubated with Ceapin A-7 or inactive analog Ceapin A-5 for 30 min at 623 
room temperature, bound to GFP-Trap_MA ChromoTek beads for 1 h at 4 C, washed with wash 624 
buffer containing Ceapin A-7 or Ceapin A-5, and eluted by boiling in SDS sample buffer.  625 
 626 
For in vitro binding studies with purified components, 6.25 nM 3XFLAG-ATF6α (2-90)-TEV-627 
MBP- HIS6X and 100 nM ABCD3-eGFP- HIS8X were incubated in lysis buffer (50 mM Tris pH 628 
7.4, 150 mM NaCl, 5 mM EDTA, 1X protease inhibitor, 0.001% LMNG) with 15-90 M 629 
Ceapin-A7 or inactive Ceapin-A5 for 30 min at room temperature. Samples were then incubated 630 
with MBP-Trap_A ChromoTek beads for 1 h at 4 C, washed with same buffer containing 631 
Ceapin A-7 or A-5 and 300 mM NaCl, and eluted by boiling in SDS sample buffer.  632 
 633 
Samples were run on a precast 4%–12% Bis-Tris polyacrylamide gel (Life Technologies) under 634 
denaturing conditions and transferred to nitrocellulose membrane. Antibodies described above 635 
for FLAG, GFP, and Pmp70 (SAB4200181) were used to detect proteins and blots were imaged 636 
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for chemiluminescence detection using a ChemiDocTM XRS+ Imaging System (Bio-Rad) 637 
(Figure 6B, 6D-E) or LICOR system (Figure 6C).  638 
 639 
Generation of recombinant proteins  640 
Human ATF6α(2-90) with an N-terminal 3XFLAG was cloned into pET16b-TEV-MBP-HIS6X 641 
(Novagen) using Gibson assembly. The construct was expressed in in BL21-Gold(DE3) E. coli 642 
cells, grown to 0.6-0.8 OD 600, and induced overnight at 16 C with 0.25 mM IPTG (Gold 643 
Biotechnology). The cells were harvested and resuspended in buffer containing 50 mM HEPES 644 
pH 7, 150 mM NaCl, 10% glycerol, 2 mM TCEP, and complete EDTA-free protease inhibitor 645 
cocktail (Roche). After lysis by sonication, the lysate was clarified at 30,000 x g for 30 min at 4 646 
C. The clarified lysate was loaded onto a HisTrap HP 5 ml column, washed in binding buffer (50 647 
mM HEPES, pH 7, 300 mM NaCl, 1 mM TCEP, 10% glycerol, and 25 mM imidazole), and 648 
eluted with a linear gradient of 25 mM to 1M imidazole in the same buffer. The ATF6α fractions 649 
eluted at 240 mM imidazole were collected and concentrated with an Amicon Ultra-15 650 
concentrator (EMD Millipore) with a 30,000-dalton molecular weight cutoff. The ATF6α 651 
concentrated fraction was loaded onto a Mono Q HR16/10 column (GE Healthcare), washed in 652 
Buffer A (50 mM HEPES, pH 7.5, 100 mM NaCl, 10% glycerol, and 1 mM DTT) and eluted 653 
with a linear gradient of 100 mM to 1M NaCl in the same buffer. Fractions were collected, 654 
concentrated as above, and loaded onto a Superdex 200 10/300 GL column (GE Healthcare) 655 
equilibrated with buffer containing 30 mM HEPES, pH 7.5, 300 mM NaCl, 5% glycerol, and 1 656 
mM DTT.  657 
 658 
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Expression and purification of human ABCD3: Full-length human ABCD3 isoform I was 659 
synthesized and cloned into modified pFastBac1 plasmid with a C-terminal -eGFP -8XHis-tag 660 
for baculoviral expression in Spodoptera frugiperda SF9 cells. Bacmid DNA was produced by 661 
transforming the recombinant pFastBac1 plasmid into E. coli DH10Bac strain. To express the 662 
protein, SF9 cells were infected with the bacmid made from recombinant pFastBac1 plasmid at 663 
multiplicity of infection (MOI) = 2 for 48 h at 27 C. The cells were harvested and resuspended 664 
in lysis buffer (50 mM Tris Cl, pH 7.5, 100 mM NaCl, 100 mM MgCl2, 10% glycerol) 665 
containing complete EDTA-free protease inhibitor cocktail (Roche), and lysed by sonication. 666 
The lysate was centrifuged at 186,010 x g for 2 h to extract the membrane fraction. 3 g of the 667 
membrane was solubilized in 30 ml of lysis buffer containing 1% w/v lauryl maltose neopentyl 668 
glycol (LMNG) (Anatrace): 0.1% w/v cholesteryl hemisuccinate (CHS) (Anatrace) overnight. 669 
Solubilized membrane was clarified by centrifugation at 104,630 x g for 30 min with 5 mM 670 
imidazole added. A HiTrap
TM
 TALON® crude 1 ml column (GE Healthcare) was equilibrated 671 
with the lysis buffer containing 5 mM imidazole and solubilized membrane loaded onto the 672 
column. After binding the column was washed with 15 ml of 10 mM imidazole, 0.02% glyco-673 
diosgenin (GDN) (Anatrace) in lysis buffer. The protein was eluted from the column with 10 ml 674 
of 150 mM imidazole, 0.02% GDN containing lysis buffer. The protein obtained was 675 
concentrated using Amicon Ultra-15 centrifugal filter units (MilliporeSigma) and size exclusion 676 
chromatography was done to further purify the protein in SEC buffer (20 mM HEPES, pH 7.5, 677 
100 mM NaCl, 2 mM MgCl2, 2% glycerol and 0.02% GDN).  678 
  679 
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Table 1. Protospacer sequence of sgRNAs 680 
Gene Protospacer 
NegCtrl GCGCCAAACGTGCCCTGACGG 
ATF6 GTGGGATCTGAGAATGTACCA 
ABCD3-1 GGTACCAGCGAGCCGGCGAG 
ABCD3-2 GACTGCCGGTACCAGCGAGC 
PEX19-1 GGCCGAAGCGGACAGGGAAT 
PEX19-2 GGAGGAAGGCTGTAGTGTCG 
ACBD4 GCCGGCCCTGCTGGACCCCG 
ACBD5 GGGAGCCGCTCTCCCACCCT 
VAPA GCACCGAACCGGTGACACAG 
VAPB GCGGGGGTCCTCTACCGGGT 
 681 
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